0001477932-17-004606.txt : 20170919 0001477932-17-004606.hdr.sgml : 20170919 20170919213927 ACCESSION NUMBER: 0001477932-17-004606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170915 FILED AS OF DATE: 20170919 DATE AS OF CHANGE: 20170919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holuka Eugene Myron CENTRAL INDEX KEY: 0001678292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38174 FILM NUMBER: 171093174 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 11TH FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001506251 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273425913 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: (908) 967-6676 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: Trail One, Inc. DATE OF NAME CHANGE: 20110314 FORMER COMPANY: FORMER CONFORMED NAME: TrailOne, Inc. DATE OF NAME CHANGE: 20101119 4 1 form4.xml FORM 4 X0306 4 2017-09-15-06:00 false 0001506251 Citius Pharmaceuticals, Inc. CTXR 0001678292 Holuka Eugene Myron C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016 true false false false Options to Purchase Common Stock 3.45 2017-09-15-06:00 4 A false 10000 0.00 A 2027-09-13-06:00 Common Stock 10000 10000 D Options to Purchase Common Stock 0.015 2024-04-14-06:00 Common Stock 2415 2415 D Options to Purchase Common Stock 12.00 2026-06-23-06:00 Common Stock 13334 13334 D The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018. The option vested in 1/3 increments over a three year period with the first installment vesting on April 14, 2015. The options vested in full on the first anniversary of the date of grant. All numbers reflect a 1-for-15 reverse stock split on June 9, 2017. /s/ Erica B. Jackson, by power of attorney 2017-09-19-06:00 EX-24 2 ex24.htm POWER OF ATTORNEY ex24.htm

EXHIBIT 24

 

POWER OF ATTORNEY

 

Known all by these presents, that the undersigned hereby constitutes and appoints each of Erica B. Jackson and W. David Mannheim, and each of them acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% or more stockholder of Citius Pharmaceuticals, Inc. (the "Company"), Forms ID, 3, 4 and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, 3, 4 or 5 (and any amendments thereto) and to file timely such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the 1934 Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 23rd day of June 2016.

 

 

 

/s/ Eugene Myron Holuka

 

 

Eugene Myron Holuka